Arturo Vegas

Arturo Vegas is an Assistant Professor at Boston University, specializing in drug delivery and biomaterials. His research focuses on developing targeted therapeutic carriers to overcome physiological barriers in diseases like cancer and diabetes. He leads the Vegas Group, which integrates chemical biology, materials science, and biomedical engineering to create novel drug delivery systems. His educational background includes a B.A. in Biology from Cornell University (2001) and a Ph.D. in Chemistry from Harvard University (2008). He completed postdoctoral research at Children’s Hospital Boston and MIT.

Research interests center on engineered approaches to improve drug efficacy and safety, including small-molecule inhibitors, nanoparticle-based therapies, and alginate-based materials for cell encapsulation. Projects emphasize targeting tumor microenvironments and modulating autoimmune responses in type 1 diabetes. Techniques span organic synthesis, biomaterial fabrication, and in vivo testing in animal models.

Key publications highlight advancements in cytokine inhibitors, anti-fibrotic biomaterials, and quantitative methods for ligand discovery. The lab’s work bridges chemistry and medicine, aiming to translate innovations into clinical applications. Ongoing efforts explore cell therapy protection via encapsulation and reducing foreign body responses to implants.

No scientific awards are explicitly listed, but his contributions to drug delivery and biomaterials are widely recognized. Advising focuses on training students in interdisciplinary research at the interface of organic chemistry and biomedical engineering.

The Vegas Group operates within Boston University’s interdisciplinary environment, collaborating with institutions like MIT and Children’s Hospital Boston. Future work includes refining targeted therapies and advancing immune-protected cell transplantation strategies.